Sort   by:  
 Page size 
Unknowntrans-K(3)[TcO(2)(CN)(4)].
Not available
S-EPMC3007308 | biostudies-literature
UnknownIncomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition.
Not available
S-EPMC2697833 | biostudies-literature
UnknownSingle Amino Acids G196 and R198 in hr1 of Subgroup K Avian Leukosis Virus Glycoprotein Are Critical for Tva Receptor Binding.
Not available
S-EPMC7772352 | biostudies-literature
UnknownEffects of sex and chronic neonatal nicotine treatment on Na²⁺/K⁺/Cl⁻ co-transporter 1, K⁺/Cl⁻ co-transporter 2, brain-derived neurotrophic factor, NMDA receptor subunit 2A and NMDA receptor subunit 2B mRNA expression in the postnatal rat hippocampus.
Not available
S-EPMC3485076 | biostudies-literature
UnknownThe neuronal K+Cl- co-transporter 2 (Slc12a5) modulates insulin secretion.
Not available
S-EPMC5431760 | biostudies-literature
UnknownMicroglial Ramification, Surveillance, and Interleukin-1β Release Are Regulated by the Two-Pore Domain K+ Channel THIK-1.
Not available
S-EPMC5783715 | biostudies-literature
UnknownModeling of an ion channel in its open conformation.
Not available
S-EPMC1366584 | biostudies-literature
MetabolomicsBiomonitoring of mycotoxins and exposomics-informed profiling in extreme preterm infants from the NeoVIP cohort

Extremely premature infants are a highly vulnerable patient group that might be exposed to a vast number of dietary and environmental contaminants, which may impact their health trajectories. This study assessed xenobiotic exposures in 26 extremely premature infants, with a special focus on dieta...

2026-06-23 | MTBLS14832 | MetaboLights
UnknownFour-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
Not available
S-EPMC6633921 | biostudies-literature
UnknownSafety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials.
Not available
S-EPMC5071715 | biostudies-literature
Sort   by:  
 Page size